A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2017

Primary Completion Date

February 1, 2018

Study Completion Date

February 1, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

BMS-986205

Single 100 mg dose on Day 1 and Day 15

Trial Locations (1)

PPD Austin Clinic, Austin